Follicular Lymphoma Lab Tests Explained
How Blood, Biopsy, and Imaging Tests Impact Treatment Decisions
How do blood test results help guide care for follicular lymphoma (FL)? What do terms like CBC, LDH, beta-2 microglobulin, and FLIPI really mean—and how are they used in monitoring and treatment planning?
In this in-depth discussion, Stephanie Chuang speaks with FL expert Dr. Celeste Bello of Moffitt Cancer Center. Together, they walk through the most important blood work and imaging tools in FL, when and how they’re used. They cover what biopsy types matter most, and how criteria like FLIPI, POD24, and GELF help determine when to start treatment.
Program Topics
What blood tests and scans reveal in FL—and when they matter most
Biopsies and diagnostic tools: flow cytometry, IHC, and imaging
Understanding prognostic tools like FLIPI, POD24, and GELF criteria
Monitoring during observation and treatment: labs, scans, and red flags
Why speaking up about subtle changes can shape your care plan
Program Panel
Program Partner
Thank you to Blood Cancer United for their partnership. They are here for you with information about clinical trials, resources, and dedicated support through their Information Specialists.
This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
This interview has been edited for clarity and length. The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story. This content does not replace professional medical advice.
Hear from people living with follicular lymphoma (FL)
Real experiences with diagnosis, treatment choices, side effects, and life beyond FL — in their own words.
